Recent increase in adverse TMP-SMX reactions in children

Recent increase in adverse TMP-SMX reactions in children
There has been a significant increase in adverse drug reactions associated with use of trimethoprim-sulfamethoxazole for treatment of skin and soft tissue infection in children, according to research published online Dec. 3 in Pediatrics.

(HealthDay)—There has been a significant increase in adverse drug reactions (ADRs) associated with use of trimethoprim-sulfamethoxazole (TMP-SMX) for treatment of skin and soft tissue infection (SSTI) in children, according to research published online Dec. 3 in Pediatrics.

Jennifer L. Goldman, M.D., from the University of Missouri in Kansas City, and colleagues conducted a retrospective chart review to characterize TMP-SMX ADRs in children, from 2000 to 2009. The Information was used to estimate the frequency of hospitalizations for TMP-SMX ADRs at 25 tertiary .

The researchers found that, at the study institution, there were five cases of TMP-SMX ADRs from 2000 to 2004, compared with 104 cases from 2005 to 2009. Of the cases, 58 percent had been treated for SSTI. Nationally, there was a similar trend, with the incidence of TMP-SMX ADRs more than doubling (P < 0.001) from 2004 to 2009 at comparable pediatric hospitals. The percentage of children prescribed TMP-SMX for SSTI sharply increased during the study period (0 to 2 percent from 2000 to 2004; 9 to 17 percent from 2005 to 2009), although national outpatient data revealed no change in overall TMP-SMX prescribing.

"TMP-SMX ADRs have occurred more frequently coincident with increased prescribing for SSTI," the authors write. "Increased usage alone may explain the increasing trend of TMP-SMX ADRs in children; however, drug-disease interaction may play a role and requires further investigation."

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

High potassium? Check your antibiotic

Jul 01, 2010

Older adults taking the antibiotic combination trimethoprim-sulfamethoxazole (TMP-SMX)—widely prescribed for urinary tract infections—are at increased risk of elevated potassium levels, called hyperkalemia, according ...

Danish children at risk from psychotropic medicines

Jun 22, 2010

Between 1998 and 2007, psychotropic medications were associated with 429 adverse drug reactions (ADRs) in children under 17 in Denmark. Researchers writing in the open access journal BMC Research Notes found that more than h ...

Recommended for you

Children may be at lower risk for Ebola virus disease

1 hour ago

(HealthDay)—Children may be at lower risk of Ebola virus disease (EVD), but physicians should be aware of the signs and symptoms, according to a viewpoint piece published online Oct. 17 in JAMA Pediatrics.

Sustained benefit for parental tobacco control program

1 hour ago

(HealthDay)—Practices that are part of a parental tobacco control intervention have higher rates of delivering tobacco control assistance to parents over a one-year follow-up period, according to a study ...

User comments